DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/z4ztq3/febrile) has announced the addition of the "Febrile Neutropenia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report to their offering. Scope: A review of the marketed products under prescription for Febrile Neutropenia, regulatory information and marketing status. Coverage of global patent coverage and detailed commentaries on the US patent challenges. Graphical representa